[1] Schouten JN, Garcia-Pagan JC, et al. Idiopathic noncirrhotic portal hypertension[J]. Hepatology, 2011, 54(3): 1071-1081.
[2] De Gottardi A, Rautou PE, Schouten J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity[J]. Lancet Gastroenterol Hepatol,2019, 4(5): 399-411.
[3] De Gottardi A, Sempoux C, Berzigotti A. Porto-sinusoidal vascular disorder[J]. J Hepatol,2022, 77(4): 1124-1135.
[4] Guido M, Alves VAF, Balabaud C, et al. International Liver Pathology Study Group. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition[J]. Histopathology, 2019, 74(2): 219-226.
[5] Verheij J, Schouten JN, Komuta M, et al. Histological features in western patients with idiopathic non-cirrhotic portal hypertension[J]. Histopathology, 2013, 62(7): 1083-1091.
[6] W?ran K, Semmler G, Jachs M, et al. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(2): e251-e266.
[7] Khan S, Saxena R. Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review[J]. Adv Anat Pathol, 2021, 28(6): 408-414.
[8] Kmeid M, Zuo C, Lagana SM, et al. Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension[J]. Diagn Pathol, 2020, 15(1): 129.
[9] Liang J, Shi C, Dupont WD, et al. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria[J]. Mod Pathol, 2021, 34(3): 592-602.
[10] Premkumar M, Anand AC. Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance[J]. J Clin Exp Hepatol, 2024,14(5): 101396.
[11] Gioia S, Baiocchini A, d′Amati G, et al. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients[J]. Dig Liver Dis. 2024, 56(2): 291-296.
[12] Burt AD, Ferrell LD, Hübscher SG. MacSween's Pathology of the Liver[J]. (8th Edition) 2022. |
